These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 3037428

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis of 3H-Tyr-D-Ala-Gly-N(Me)Phe chloromethyl ketone--an opioid affinity label.
    Varga E, Tóth G, Hepp J, Benyhe S, Simon J, Medzihradszky K, Borsodi A.
    Neuropeptides; 1988 Oct; 12(3):135-9. PubMed ID: 2853836
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Opioid receptor labeling with the chloromethyl ketone derivative of (3)H-Tyr-D-Ala-Gly-(Me)Phe-Gly-ol (DAMGO) I: Binding properties of 3H-Tyr-D-Ala-Gly-(Me)Phe chloromethyl.
    Oktem HA, Varga E, Hepp J, Medzihradzky K, Lajtha A, Borsodi A.
    Life Sci; 1991 Oct; 48(18):1757-62. PubMed ID: 1850494
    [Abstract] [Full Text] [Related]

  • 5. Affinity labelling of frog brain opioid receptors by dynorphin(1-10) chloromethyl ketone.
    Benyhe S, Ketevan A, Simon J, Hepp J, Medzihradszky K, Borsodi A.
    Neuropeptides; 1997 Feb; 31(1):52-9. PubMed ID: 9574838
    [Abstract] [Full Text] [Related]

  • 6. Opioid receptor labeling with the chloromethyl ketone derivative of [3H]Tyr-D-Ala-Gly-(Me)Phe-Gly-ol (DAMGO) II: Covalent labeling of mu opioid binding site by 3H-Tyr-D-Ala-Gly-(Me)Phe chloromethyl ketone.
    Oktem HA, Moitra J, Benyhe S, Toth G, Lajtha A, Borsodi A.
    Life Sci; 1991 Feb; 48(18):1763-8. PubMed ID: 1850495
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The mu-opioid receptor in the 7315c tumor cell.
    Tocque B, Jacobson AE, Rice KC, Frey EA.
    Eur J Pharmacol; 1987 Nov 03; 143(1):127-30. PubMed ID: 2826184
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Covalent labeling of opioid receptors with 3H-D-Ala2-Leu5-enkephalin chloromethyl ketone. II. Binding characteristics in frog brain membranes.
    Simon J, Szücs M, Benyhe S, Tóth G, Hepp J, Borsodi A, Wollemann M, Medzihradszky K.
    Life Sci; 1987 Jul 13; 41(2):185-92. PubMed ID: 3037221
    [Abstract] [Full Text] [Related]

  • 15. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC, Kouakou Y, Puget A, Moisand C.
    Mol Pharmacol; 1983 Jul 13; 24(1):23-9. PubMed ID: 6306437
    [Abstract] [Full Text] [Related]

  • 16. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
    Amiche M, Sagan S, Mor A, Pelaprat D, Rostene W, Delfour A, Nicolas P.
    Eur J Biochem; 1990 May 20; 189(3):625-35. PubMed ID: 2161761
    [Abstract] [Full Text] [Related]

  • 17. A potent peptide affinity reagent for the opiate receptor.
    Venn RF, Barnard EA.
    J Biol Chem; 1981 Feb 25; 256(4):1529-32. PubMed ID: 6257675
    [Abstract] [Full Text] [Related]

  • 18. Affinity labeling of delta opioid receptors by an enkephalin-derivative alkylating agent, DSLET-Mal.
    Szatmári I, Orosz G, Medzihradszky K, Borsodi A.
    Biochem Biophys Res Commun; 1999 Nov 19; 265(2):513-9. PubMed ID: 10558900
    [Abstract] [Full Text] [Related]

  • 19. Differences of binding characteristics of non-selective opiates towards mu and delta receptor types.
    Delay-Goyet P, Roques BP, Zajac JM.
    Life Sci; 1987 Aug 10; 41(6):723-31. PubMed ID: 3039270
    [Abstract] [Full Text] [Related]

  • 20. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW, Liu-Chen LY.
    J Pharmacol Exp Ther; 1986 Nov 10; 239(2):351-7. PubMed ID: 3021954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.